[Drug-induced interstitial pneumonitis due to avelumab: A case report].

CONCLUSION: Avelumab can induce interstitial lung disease. The mechanism is uncertain and requires further studies. Monitoring of respiratory function and CT scanning are necessary for its early management. PMID: 30318432 [PubMed - as supplied by publisher] (Source: Revue des Maladies Respiratoires)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2OuiWcs